/ CompletedNot ApplicableIIT Effect of Oral Supplementation With One Form of L-arginine on Vascular Endothelial Function in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.
The purpose of this study is to determine whether oral supplementation with one form of arginine improves vascular endothelial function in healthy subjects with risk factors associated with the metabolic syndrome
/ CompletedNot ApplicableIIT Characterization of the Metabolic Fate of an Oral L-arginine Form in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.
The purpose of this study is to compare the metabolic fate of two oral forms of L-Arginine in healthy subjects featuring metabolic syndrome related risk factors
/ Not yet recruitingNot Applicable A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy - BEST- Diabetes study (Befiradol Dose-Finding Study in diabetic patients)
100 Clinical Results associated with Institut de Recherche Pierre Fabre SAS
0 Patents (Medical) associated with Institut de Recherche Pierre Fabre SAS
100 Deals associated with Institut de Recherche Pierre Fabre SAS
100 Translational Medicine associated with Institut de Recherche Pierre Fabre SAS